**Core Concept:** Skeletal muscle relaxants are medications used to relieve muscle spasms and hypertonia. They work by inhibiting the release of excitatory neurotransmitters, such as acetylcholine, at the neuromuscular junction.

**Why the Correct Answer is Right:** The correct answer, **Dantrolene (Dantrolene sodium)**, works by selectively blocking the release of calcium ions from the sarcoplasmic reticulum in skeletal muscle cells. This inhibition leads to the relaxation of muscles and the reduction of spasms. Dantrolene does not cause pain on injection because it is a specific skeletal muscle relaxant with minimal systemic effects.

**Why Each Wrong Option is Incorrect:**

A. **Pentobarbital (Narcotine):** This is a barbiturate drug, not a skeletal muscle relaxant. Barbiturates are central nervous system depressants that induce sedation, respiratory depression, and unconsciousness. Injection of pentobarbital would likely cause severe adverse effects and not be associated with muscle pain.

B. **Methocarbamol (Robaxin):** Methocarbamol is a centrally acting muscle relaxant that belongs to the class of drugs known as benzhydryl derivatives (e.g., tubocurarine). It is formulated as a racemic mixture of two enantiomers (R and S). Although methocarbamol may cause pain on injection, it is less likely to do so compared to other options due to its central mode of action.

C. **Suxamethonium (Succinylcholine):** Suxamethonium is an acetylcholinesterase inhibitor, specifically a non-depolarizing muscle relaxant. Its injection causes rapid and profound muscle relaxation via the blockade of acetylcholine degradation, leading to increased acetylcholine levels at the neuromuscular junction. Pain upon injection is a known phenomenon with suxamethonium due to its direct effect on the neuromuscular junction, unlike the other options which act centrally.

**Clinical Pearls:**

1. Pain on injection is a known adverse effect of certain muscle relaxants, especially those acting directly at the neuromuscular junction like suxamethonium. This could be explained by the direct effect of these drugs on the neuromuscular junction and their short half-life. In contrast, centrally acting muscle relaxants like methocarbamol have a more prolonged effect and are less likely to cause pain on injection.

2. In clinical practice, healthcare professionals are cautious about the potential for pain on injection when administering muscle relaxants. They may choose the appropriate muscle relaxant based on the desired duration of action and patient's condition. For instance, if rapid onset and short duration of action is required, suxamethonium may be chosen, while methocarbamol is more suitable for longer duration of action.

3. Pain on injection can be managed with proper aseptic technique, ensuring speedy administration and minimizing trauma to the muscle during injection. In rare cases, if pain is severe, an alternative muscle relaxant should be considered.

4. Pain